Novo Nordisk signed a deal worth as much as €1.165 billion with Sweden’s Nanexa for rights to its drug delivery technology for obesity and diabetes treatments https://www.bloomberg.com/news/articles/2026-09-25/novo-signs-delivery-deal-with-nanexa-worth-up-to-1-3-billion?taid=6ab61f78a627190001d5eef8&utm_campaign=trueanthem&utm_content=business&utm_medium=social&utm_source=twitter